Johnson & Johnson (JNJ) Common Equity (2009 - 2026)
Johnson & Johnson (JNJ) posted Common Equity of $84.97 billion for Q2 2026, up 8.3% from $78.47 billion a year earlier and up 4.7% from the prior quarter.
Johnson & Johnson (JNJ) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Johnson & Johnson's Common Equity came in at $81.54 billion, up 14.1% from FY2024.
- Annual Common Equity shows a four-year compound annual growth rate of 6.5% (FY2021 to FY2025).
- In prior years, Johnson & Johnson's Common Equity was $71.49 billion in FY2024 (+3.9%), $68.77 billion in FY2023 (-10.5%), $76.8 billion in FY2022 and $63.28 billion in FY2021.
- The Q2 2026 figure stands as the highest quarterly Common Equity in data going back to Q4 2011.
- On a year-over-year basis, Common Equity has increased in each of the last seven quarters, with growth averaging 7.9% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q4 2025, with growth of 14.1%; the weakest was Q4 2023, with a decline of 10.5%.
- According to Business Quant data, Common Equity for the three prior quarters was $81.19 billion (Q1 2026), $81.54 billion (Q4 2025) and $79.28 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Vertex Pharmaceuticals | 133.33 Bn | 105.34 Bn | 2.84 Bn | 20.25 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 84.97 Bn |
| Mar 29, 2026 | 81.19 Bn |
| Dec 28, 2025 | 81.54 Bn |
| Sep 28, 2025 | 79.28 Bn |
| Jun 29, 2025 | 78.47 Bn |
| Mar 30, 2025 | 78.11 Bn |
| Dec 29, 2024 | 71.49 Bn |
| Sep 29, 2024 | 70.16 Bn |
| Jun 30, 2024 | 71.54 Bn |
| Mar 31, 2024 | 70.02 Bn |
| Dec 31, 2023 | 68.77 Bn |
| Oct 1, 2023 | 71.23 Bn |
| Jul 2, 2023 | 76.41 Bn |
| Apr 2, 2023 | 70.87 Bn |
| Jan 1, 2023 | 76.80 Bn |
| Oct 2, 2022 | 74.60 Bn |
| Jul 3, 2022 | 76.36 Bn |
| Apr 3, 2022 | 74.71 Bn |
| Jan 2, 2022 | 74.02 Bn |
| Oct 3, 2021 | 70.27 Bn |
Johnson & Johnson Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=JNJ&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();